{"id":"https://openalex.org/W2185895448","doi":null,"title":"Article: Treatment Oral anti-diabetic drugs for the prevention of Type 2 diabetes","display_name":"Article: Treatment Oral anti-diabetic drugs for the prevention of Type 2 diabetes","publication_year":2011,"publication_date":"2011-01-01","ids":{"openalex":"https://openalex.org/W2185895448","mag":"2185895448"},"language":"en","primary_location":{"id":"mag:2185895448","doi":null,"is_oa":false,"landing_page_url":"http://www.dobreprogramyzdrowotne.pl/uploaded/file/cukrzyca/prewencja/Phung%202011.PDF","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108104371","display_name":"Olivia J Phung","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Olivia J Phung","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045621916","display_name":"Nitesh A. Sood","orcid":"https://orcid.org/0000-0003-3603-538X","observed_orcids":["https://orcid.org/0000-0003-3603-538X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nitesh Sood","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077726343","display_name":"Bruce E. Sill","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bruce Sill","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5065282629","display_name":"Craig Ian Coleman","orcid":"https://orcid.org/0000-0003-4868-7158","observed_orcids":["https://orcid.org/0000-0003-4868-7158"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Craig I Coleman","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4868-7158","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.012500000186264515,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11140","display_name":"Natural Antidiabetic Agents Studies","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes-prevention","display_name":"type 2 diabetes prevention","score":0.9570000171661377},{"id":"https://openalex.org/keywords/oral-antidiabetic-drugs","display_name":"oral antidiabetic drugs","score":0.9890000224113464},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.9800000190734863},{"id":"https://openalex.org/keywords/alpha-glucosidase-inhibitors","display_name":"alpha-glucosidase inhibitors","score":0.9810000061988831},{"id":"https://openalex.org/keywords/biguanides","display_name":"biguanides","score":0.9959999918937683},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.996999979019165},{"id":"https://openalex.org/keywords/glinides","display_name":"glinides","score":0.9729999899864197},{"id":"https://openalex.org/keywords/high-risk-patients","display_name":"high-risk patients","score":0.6930000185966492},{"id":"https://openalex.org/keywords/number-needed-to-treat","display_name":"number needed to treat","score":0.9800000190734863}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9022418856620789},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.7784157991409302},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.689956545829773},{"id":"https://openalex.org/C82789193","wikidata":"https://www.wikidata.org/wiki/Q2142611","display_name":"Relative risk","level":3,"score":0.6823806762695312},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.6242020130157471},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5801857113838196},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5254829525947571},{"id":"https://openalex.org/C187960798","wikidata":"https://www.wikidata.org/wiki/Q7631152","display_name":"Subgroup analysis","level":3,"score":0.4342862665653229},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3305990695953369},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.2693687975406647},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.22309809923171997}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2185895448","doi":null,"is_oa":false,"landing_page_url":"http://www.dobreprogramyzdrowotne.pl/uploaded/file/cukrzyca/prewencja/Phung%202011.PDF","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W18722868","https://openalex.org/W80900669","https://openalex.org/W121348928","https://openalex.org/W143876065","https://openalex.org/W193344510","https://openalex.org/W1522960617","https://openalex.org/W1855278889","https://openalex.org/W1965055157","https://openalex.org/W1967302382","https://openalex.org/W1975777549","https://openalex.org/W1978288432","https://openalex.org/W1981101443","https://openalex.org/W1983130632","https://openalex.org/W1985882361","https://openalex.org/W1986215651","https://openalex.org/W2006625394","https://openalex.org/W2013354239","https://openalex.org/W2015852718","https://openalex.org/W2016622896","https://openalex.org/W2041166009","https://openalex.org/W2047926237","https://openalex.org/W2066039558","https://openalex.org/W2073796939","https://openalex.org/W2078508655","https://openalex.org/W2090609048","https://openalex.org/W2096691922","https://openalex.org/W2098289172","https://openalex.org/W2105669432","https://openalex.org/W2107328434","https://openalex.org/W2113144077","https://openalex.org/W2115607452","https://openalex.org/W2123744385","https://openalex.org/W2127125241","https://openalex.org/W2129241702","https://openalex.org/W2131136365","https://openalex.org/W2132594773","https://openalex.org/W2134235461","https://openalex.org/W2134293572","https://openalex.org/W2134599810","https://openalex.org/W2142414788","https://openalex.org/W2146901298","https://openalex.org/W2147617075","https://openalex.org/W2158822657","https://openalex.org/W2159160099","https://openalex.org/W2159854507","https://openalex.org/W2166142258","https://openalex.org/W2185461071","https://openalex.org/W2345903479","https://openalex.org/W2596624061"],"related_works":["https://openalex.org/W1592280702","https://openalex.org/W1832567073","https://openalex.org/W2120774442","https://openalex.org/W1974315257","https://openalex.org/W2214099822","https://openalex.org/W7096860865","https://openalex.org/W2271376467","https://openalex.org/W7095317802","https://openalex.org/W7042265697","https://openalex.org/W2135098417"],"abstract_inverted_index":{"Aim":[0],"To":[1],"determine":[2],"the":[3,12,57,96,122,151],"comparative":[4],"efficacy":[5],"of":[6,14,23,63,99,125,150],"oral":[7,36],"anti-diabetic":[8,37],"drugs":[9,38],"in":[10,39],"preventing":[11],"development":[13],"Type":[15,46,65],"2":[16,47,66],"diabetes.":[17,48],"Methods":[18],"A":[19],"systematic":[20],"literature":[21],"search":[22],"MEDLINE,":[24],"EMBASE":[25],"and":[26,60,92,105,112,132,185,208,218,222,228],"Cochrane":[27],"CENTRAL":[28],"was":[29],"conducted":[30],"for":[31,44],"randomized":[32],"controlled":[33],"trials":[34,77],"evaluating":[35,162],"patients":[40],"at":[41],"high":[42],"risk":[43,61,98,124,137,143,163,203,212],"developing":[45,64,100],"Mixed-treatment":[49],"comparison":[50,87],"meta-analysis":[51],"methods":[52],"were":[53,83,153],"used":[54],"to":[55,172,181,190,195],"evaluate":[56],"relative":[58,97,123],"risks":[59],"differences":[62,164],"diabetes,":[67],"along":[68],"with":[69,109,130,166,206,210],"associated":[70,209],"95%":[71],"credible":[72,146],"intervals.":[73],"Results":[74],"Overall,":[75],"20":[76],"(n":[78],"=":[79,174,183,192],"23":[80],"230":[81],"participants)":[82],"included.":[84],"Upon":[85],"mixed-treatment":[86],"meta-analysis,":[88],"thiazolidinediones,":[89],"alpha-glucosidase":[90,140,176],"inhibitors":[91,141,177,217],"biguanides":[93,131,186,219],"significantly":[94,120],"reduced":[95,121],"diabetes":[101,126],"by":[102,127],"64,":[103],"40":[104],"27%,":[106],"respectively,":[107],"compared":[108,129,165,205],"control.":[110],"Sulphonylureas":[111],"glinides":[113,229],"showed":[114],"no":[115,231],"significant":[116,197,232],"effect.":[117],"Moreover,":[118],"thiazolidinediones":[119,168],"50%":[128],"trended":[133],"towards":[134],"a":[135],"40%":[136],"reduction":[138,204,213],"vs.":[139],"[relative":[142],"0.60":[144],"(95%":[145],"intervals":[147],"0.34\u20101.02)].":[148],"None":[149],"results":[152],"appreciably":[154],"altered":[155],"upon":[156],"subgroup":[157],"or":[158],"sensitivity":[159],"analyses.":[160],"When":[161],"control,":[167,225],"()9%,":[169],"number":[170,179,188],"needed":[171,180,189],"treat":[173,182,191],"11),":[175],"()7%,":[178,187],"14)":[184,193],"continued":[194],"show":[196],"benefit.":[198,233],"Conclusions":[199],"Oftheoralanti-diabeticdrugsevaluatedtopreventType":[200],"2diabetes,thiazolidinedioneswereassociatedwiththe":[201],"greatest":[202],"control":[207],"greater":[211],"than":[214,224],"biguanides.":[215],"Alpha-glucosidase":[216],"performed":[220],"similarly,":[221],"better":[223],"while":[226],"sulphonylureas":[227],"provided":[230],"Diabet.":[234],"Med.":[235],"28,":[236],"948\u2010964":[237],"(2011)":[238]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}